Canada Life’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.6M | Buy |
|
|||||
|
2025
Q2 | $29.7M | Buy |
|
|||||
|
2025
Q1 | $22.7M | Buy |
|
|||||
|
2024
Q4 | $18.1M | Buy |
|
|||||
|
2024
Q3 | $18.9M | Buy |
|
|||||
|
2024
Q2 | $13.2M | Buy |
|
|||||
|
2024
Q1 | $7.11M | Buy |
|
|||||
|
2023
Q4 | $8.7M | Buy |
|
|||||
|
2023
Q3 | $7.82M | Sell |
|
|||||
|
2023
Q2 | $8.59M | Buy |
|
|||||
|
2023
Q1 | $8.63M | Buy |
|
|||||
|
2022
Q4 | $10.1M | Sell |
|
|||||
|
2022
Q3 | $8.51M | Sell |
|
|||||
|
2022
Q2 | $7.29M | Sell |
|
|||||
|
2022
Q1 | $10.8M | Buy |
|
|||||
|
2021
Q4 | $8.71M | Sell |
|
|||||
|
2021
Q3 | $12.8M | Sell |
|
|||||
|
2021
Q2 | $12M | Sell |
|
|||||
|
2021
Q1 | $11.2M | Buy |
|
|||||
|
2020
Q4 | $9.41M | Buy |
|
|||||
|
2020
Q3 | $8.85M | Sell |
|
|||||
|
2020
Q2 | $9.06M | Buy |
|
|||||
|
2020
Q1 | $5.05M | Buy |
|
|||||
|
2019
Q4 | $5.26M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.06M | Sell |
|
|||||
|
2019
Q1 | $4.89M | Buy |
|
|||||
|
2018
Q4 | $2.73M | Sell |
|
|||||
|
2018
Q3 | $3.44M | Sell |
|
|||||
|
2018
Q2 | $4.75M | Buy |
|
|||||
|
2018
Q1 | $5.55M | Buy |
|
|||||
|
2017
Q4 | $3.85M | Buy |
|
|||||
|
2017
Q3 | $1.05M | Buy |
|
|||||
|
2017
Q2 | $653K | Hold |
|
|||||
|
2017
Q1 | $420K | Sell |
|
|||||
|
2016
Q4 | $973K | Sell |
|
|||||
|
2016
Q3 | $2.77M | Hold |
|
|||||
|
2016
Q2 | $2.26M | Buy |
|
|||||
|
2016
Q1 | $2.55M | Buy |
|
|||||
|
2015
Q4 | $3.41M | Buy |
|
|||||
|
2015
Q3 | $2.9M | Buy |
|
|||||
|
2015
Q2 | $1.42M | Buy |
|
|||||
|
2015
Q1 | $658K | Buy |
|
|||||
|
2014
Q4 | $524K | Buy |
|
|||||
|
2014
Q3 | $337K | Hold |
|
|||||
|
2014
Q2 | $270K | Hold |
|
|||||
|
2014
Q1 | $287K | Hold |
|
|||||
|
2013
Q4 | $278K | Buy |
|